• June 3-6, 2024
  • San Diego Convention Center, California

Sessions

Loading

Kernal Bio

Monday, June 03, 2024
Oncology
Company Presentation Theater 1
Kernal Bio is a VC-backed biotech company developing mRNA 2.0 immunotherapies. Kernal mines translatome data to discover cell-specific sequence features and design mRNAs that are selectively translated in cancer cells. These mRNAs are formulated with proprietary, best-in-class LNPs validated in non-human primates (NHPs). Our development candidates have remarkably wide therapeutic index (100x) and are delivered with extrahepatic LNPs. Lead program shows high efficacy and safety in solid tumors resistant to all other immuno-oncology agents and is tolerated well in NHPs. With roots at MIT, Harvard, Merck, and BMS, Kernal’s management team has deep expertise in mRNA therapeutics with three FDA approvals and 120+ patents. Based in Cambridge, MA, the company is backed by Hummingbird Ventures, Amgen Ventures, HBM Partners, NASA, and Boeing.
Kernal Bio
Company Website: https://kernalbio.com/
Lead Product in Development: KR-335
Number Of Unlicensed Products (For Which You Are Seeking Partners): 4

Company HQ City

Cambridge

Company HQ State

Massachusetts

Company HQ Country

United States

CEO/Top Company Official

Yusuf Erkul, MD, MBA

Development Phase of Primary Product

Pre-Clinical
Primary Speaker
YUSUF ERKUL, MD
CEO
Kernal Biologics
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS